acetic acid and Cancer of Cervix studies

Acetic Acid: Product of the oxidation of ethanol and of the destructive distillation of wood. It is used locally, occasionally internally, as a counterirritant and also as a reagent. (Stedman, 26th ed)
acetic acid : A simple monocarboxylic acid containing two carbons.

Research Excerpts

Excerpt	Relevance	Reference
"Proportion of CIN II/III lesion on cervical biopsy among screen-positive women of age group < 40 years and ≥ 40 years undergoing screening for carcinoma cervix by Pap smear and visual inspection of cervix with acetic acid (VIA) was determined (both the tests were performed on same population)."	7.78	Is visual inspection with acetic acid better than cervical cytology to screen women ≥ 40 years of age for carcinoma cervix? A cross-sectional study on proportion of screen-positive women (by VIA and cervical cytology) having CIN II/III lesion on cervical ( Bhattacharya, S; Dasgupta, S, 2012)
"The objective of this study was to determine whether the presence of cervicitis influenced the accuracy of visual inspection with acetic acid (VIA)."	7.74	Effect of cervicitis on visual inspection with acetic acid. ( Cortessis, VK; Cremer, M; Davis-Dao, CA; Felix, J, 2008)
"Women enrolled in HIV care at the Family AIDS Care and Education Services clinic in Kisumu, Kenya, were recruited for participation."	5.42	Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. ( Abdulrahim, N; Bukusi, EA; Cohen, CR; Huchko, MJ; Maloba, M; Sawaya, G; Smith-McCune, K; Sneden, J, 2015)
"However, variable sensitivity and specificity have been observed in various community based studies."	5.39	Reasons for variation in sensitivity and specificity of visual inspection with acetic acid (VIA) for the detection of pre- cancer and cancer lesions of uterine cervix. ( Parashari, A; Singh, V, 2013)
"The Ovid (Medline) electronic database from January, 1996 to Febuary, 2007 was searched, using the following key search words of (1) MESH term "Uterine Cervical Neoplasms" with subheading "diagnosis", (2) Keywords "sensitivity" or "specificity" and (3) Keyword "visual inspection with acetic acid" Total of 11 studies were relevant and eligible for the review."	4.86	Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: a systematic review. ( Sritipsukho, P; Thaweekul, Y, 2010)
"Liquid based cytology was more efficacious to diagnose atypical cells with higher sensitivity and specificity in comparison to that of visual Inspection with Acetic Acid test."	3.96	Evaluation of Visual Inspection of Cervix with Acetic Acid and Liquid Based in Cervical Cancer Screening with Cervical Biopsy. ( Joshi, R; Malla Vaidya, K; Shrestha, B, 2020)
"visual inspection of cervix with acetic acid is an effective screening tool with comparable sensitivity and specificity."	3.91	Evaluation of Abnormal Cervix with Visual Inspection under Acetic Acid and Colposcopy. ( Bajracharya, N; Bhattachan, K; Dangal, G; Karki, A; Parajuli, S; Poudel, R; Pradhan, HK; Shrestha, R; Tiwari, K, 2019)
" The objectives of MECCS II are (1) to compare the sensitivity and specificity for cervical intraepithelial neoplasia (CIN) 3 or cancer of self-collected vaginal specimens tested for high-risk types of the human papillomavirus (HR-HPV) by APTIMA with those tested for HR-HPV by Hybrid Capture 2 (HC2); and (2) determine the efficacy of cryotherapy in the treatment of HR-HPV-positive and acetic acid-aided visual inspection (VIA)-positive and -negative women after VIA triage."	3.79	Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection. ( Belinson, J; Belinson, S; Booth, C; Brainard, J; Chávez-Avilés, MN; Chiesa-Vottero, A; Enerson, CL; Nagore, N; Nieves, L; Pérez, AG, 2013)
"To determine the feasibility and efficiency of the "see and treat" approach using visual inspection acetic acid (VIA) and enhanced digital imaging (EDI) for cervical cancer prevention in HIV-infected women."	3.78	Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. ( de Klerk, R; Friedman, HM; Monare, B; Ramogola-Masire, D; Ratshaa, B; Zetola, NM, 2012)
"Proportion of CIN II/III lesion on cervical biopsy among screen-positive women of age group < 40 years and ≥ 40 years undergoing screening for carcinoma cervix by Pap smear and visual inspection of cervix with acetic acid (VIA) was determined (both the tests were performed on same population)."	3.78	Is visual inspection with acetic acid better than cervical cytology to screen women ≥ 40 years of age for carcinoma cervix? A cross-sectional study on proportion of screen-positive women (by VIA and cervical cytology) having CIN II/III lesion on cervical ( Bhattacharya, S; Dasgupta, S, 2012)
"To determine the sensitivity and specificity of optical coherence tomography (OCT) as an adjunct to unaided visual inspection using acetic acid (VIA) in the detection of cervical intraepithelial neoplasia 2 (CIN 2) in a real-time clinical evaluation."	3.76	Study of the diagnostic efficacy of real-time optical coherence tomography as an adjunct to unaided visual inspection with acetic acid for the diagnosis of preinvasive and invasive neoplasia of the uterine cervix. ( Belinson, JL; Belinson, SE; Mohr, M; Rasool, N; Rong, X; Tresser, NJ; Wang, C; Wu, R; Wulan, N; Yang, B; Zhang, W; Zhu, Y, 2010)
"This study aimed to evaluate the association between risk factors for uterine cervical neoplasms and cervical lesions by HPV by comparison of the visual inspection with acetic acid (VIA), cytology and cervicography results."	3.76	[Risk factors for uterine cervical cancer according to results of VIA, cytology and cervicography]. ( de Almeida, PC; dos Anjos, Sde J; Franco, ES; Pinheiro, AK; Vasconcelos, CT, 2010)
"The objective of this study was to determine whether the presence of cervicitis influenced the accuracy of visual inspection with acetic acid (VIA)."	3.74	Effect of cervicitis on visual inspection with acetic acid. ( Cortessis, VK; Cremer, M; Davis-Dao, CA; Felix, J, 2008)
"Several studies have shown impressive sensitivity and specificity of visual inspection using acetic acid wash (VIA) in detecting cervical dysplasia."	3.72	Risk factors as the basis for triage in low-resource cervical cancer screening programs. ( Ahmed, S; Blumenthal, PD; Chen, YQ; Gaffikin, L; McGrath, JM, 2003)
"The objective of this study was to estimate the sensitivity and specificity of visual inspection with acetic acid and magnification (VIAM) using the AviScope device to confirm high-grade cervical intraepithelial neoplasia or carcinoma."	3.72	Confirmation of cervical neoplasia using a hand-held, lighted magnification device. ( Bishop, A; Scott, R; Sellors, JW; Tsu, VD; Winkler, JL, 2003)
" The aim of this study was to analyze the sensitivity and specificity of acetic acid smear test as a cervical cancer screening test, and evaluate the value of this method for cervical cancer screening."	3.72	[Value of acetic acid smear test for cervical cancer screening]. ( Belinson, JL; Li, L; Li, N; Pan, QJ; Pretorius, RG; Qiao, YL; Rong, SD; Wu, LY; Zhang, WH; Zhao, FH, 2003)
"To estimate the sensitivity and specificity of visual inspection using acetic acid as a primary screen for cervical intraepithelial neoplasia (CIN)."	3.71	Cervical cancer screening by simple visual inspection after acetic acid. ( Belinson, JL; Elson, P; Pretorius, RG; Qiao, YL; Wu, LY; Zhang, WH, 2001)
"In all, 218 women with abnormal cervical cancer screening results including cytology and/or human papillomavirus (HPV) test were involved in the randomized controlled trial."	3.30	Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial. ( Li, P; Li, W; Liu, X; Lu, J; Lu, W; Wang, C; Wei, J; Xi, L; Zhou, Y, 2023)
"An important cervical cancer prevention strategy in low- and middle-income countries (LMICs) has been single-visit screen-and-treat (SV-SAT) approach, using visual inspection with acetic acid (VIA) and ablative treatment with cryotherapy to manage precancerous lesions."	3.30	Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya. ( Barnabas, RV; Baynes, C; Fridah, H; Gimbel, S; Heitner, J; Kerubo, MB; Mugo, NR; Ngure, K; Oluoch, LM; Pinder, LF; Shin, MB; Thomas, KK, 2023)
"Game Changers for Cervical Cancer Prevention (GC-CCP), a group advocacy training intervention, has been shown to increase cervical cancer prevention and screening advocacy."	3.30	Knowledge Mediates the Effects of Game Changers for Cervical Cancer Prevention (GC-CCP) Intervention on Increased VIA Screening Advocacy in Uganda. ( Beyeza-Kashesya, J; Juncker, M; Matovu, JKB; Namisango, E; Wagner, GJ; Wanyenze, RK, 2023)
"Enhancing cervical cancer knowledge among women who have screened for cervical cancer is key to empowering these women to engage in cervical cancer prevention advocacy and acting as change agents for encouraging other women to screen."	3.30	Knowledge Mediates the Effects of Game Changers for Cervical Cancer Prevention (GC-CCP) Intervention on Increased VIA Screening Advocacy in Uganda. ( Beyeza-Kashesya, J; Juncker, M; Matovu, JKB; Namisango, E; Wagner, GJ; Wanyenze, RK, 2023)
"Hence the majority of cervical cancer patients visiting the hospitals are diagnosed at advanced stage, often leading to poor survival rate."	3.01	A Comprehensive Review of Cervical Cancer Screening Devices: The Pros and the Cons. ( Chong, PP; Choo, HL; Hon, HJ; Khine, PP, 2023)
"In Ethiopia, the standard method of cervical cancer screening is using Visual Inspection with Acetic Acid (VIA)."	2.90	Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial. ( Abebe, T; Addissie, A; Gizaw, M; Jemal, A; Kantelhardt, EJ; Kaufmann, AM; Ruddies, F; Teka, B; Wienke, A; Worku, A, 2019)
"Pooled rate-ratio of invasive cervical cancer was 0."	2.82	Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis. ( Daniel, RA; Kumar, D; Lohiya, A; Nongkynrih, B; Rath, RS; S A, R; Varghese, C, 2022)
"VIA screening may lead to reduction in cervical cancer and all-cause mortality in long run."	2.82	Effectiveness of Visual Inspection with Acetic Acid (VIA) Screening on Cervical Cancer Mortality and Incidence - A Systematic Review and Meta-Analysis. ( Daniel, RA; Kumar, D; Lohiya, A; Nongkynrih, B; Rath, RS; S A, R; Varghese, C, 2022)
"To compare two cervical cancer screening methods: community-based self-collection of high-risk human papillomavirus (HR-HPV) testing and visual inspection with acetic acid (VIA)."	2.80	Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial. ( Biryabarema, C; Byamugisha, JK; Mitchell, SM; Money, DM; Moses, E; Mwesigwa, D; Ogilvie, GS; Pedersen, HN; Sekikubo, M; Singer, J, 2015)
"Self-collection-based cervical cancer screening had a higher uptake than VIA."	2.80	Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial. ( Biryabarema, C; Byamugisha, JK; Mitchell, SM; Money, DM; Moses, E; Mwesigwa, D; Ogilvie, GS; Pedersen, HN; Sekikubo, M; Singer, J, 2015)
"The incidence of invasive cervical cancer was 26."	2.79	Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. ( Badwe, RA; Dikshit, R; Gupta, S; Mishra, GA; Mittra, I; Shastri, SS; Singh, S, 2014)
"Cervical cancer is the leading cause of cancer mortality among women in India."	2.79	Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. ( Badwe, RA; Dikshit, R; Gupta, S; Mishra, GA; Mittra, I; Shastri, SS; Singh, S, 2014)
"A single-visit approach to cervical cancer prevention in Roi Et province using visual inspection with acetic acid and cryotherapy appeared to have an effect in revealing an increased cervical cancer incidence rate by achieving higher coverage, resulting in increased case finding."	2.75	Effect of single-visit VIA and cryotherapy cervical cancer prevention program in Roi Et, Thailand: a preliminary report. ( Blumenthal, PD; Chumworathayi, B; Kamsa-Ard, S; Limpaphayom, KK; Supaatakorn, P; Wongsena, M, 2010)
"In Mexico, cervical cancer is the second leading cause of death in women after breast cancer."	2.75	[Comparison of the diagnostic utility from visual inspection with acetic acid and cervical cytology]. ( Aguilar-Durán, M; Arreola-Herrera, Fde A; Cisneros-Pérez, V; Lares-Bayona, EF; Milla-Villeda, RH; Navarrete-Flores, JA; Núñez-Márquez, T; Rueda-Cisneros, DA; Sánchez-Anguiano, LF; Velázquez-Hernández, N, 2010)
"In the HPV-testing group, cervical cancer was diagnosed in 127 subjects (of whom 39 had stage II or higher), as compared with 118 subjects (of whom 82 had advanced disease) in the control group (hazard ratio for the detection of advanced cancer in the HPV-testing group, 0."	2.74	HPV screening for cervical cancer in rural India. ( Budukh, AM; Chinoy, R; Desai, S; Dinshaw, KA; Hingmire, S; Jayant, K; Kane, S; Kelkar, R; Keskar, VR; Kothari, A; Malvi, SG; Muwonge, R; Nene, BM; Panse, N; Rajeshwarkar, R; Sankaranarayanan, R; Shastri, SS; Thorat, R, 2009)
"The primary outcome measures were cervical cancer incidence and mortality."	2.73	Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. ( Cherian, J; Esmy, PO; Fayette, JM; Muwonge, R; Rajkumar, R; Sankaranarayanan, R; Shanthakumari, S; Swaminathan, R, 2007)
"Cervical cancer is the most common cancer among women in developing countries."	2.73	Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. ( Cherian, J; Esmy, PO; Fayette, JM; Muwonge, R; Rajkumar, R; Sankaranarayanan, R; Shanthakumari, S; Swaminathan, R, 2007)
"Cervical cancer is the leading cause of cancer death among women in developing countries."	2.73	Is magnification necessary to confirm visual inspection of cervical abnormalities? A randomized trial in Peru. ( Del Aguila, R; Delgado, JM; Gonzales, M; Lewis, K; Sellors, JW; Tsu, VD; Winkler, JL, 2008)
"Overall, 97 and 34 incident cervical cancer cases were observed in the intervention and control arms, respectively."	2.71	Initial results from a randomized trial of cervical visual screening in rural south India. ( Bagyalakshmi, KR; Cherian, J; Esmy, PO; Frappart, L; Jeevan, D; Lucas, E; Mahe, C; Muwonge, R; Parkin, DM; Rajkumar, R; Sankaranarayanan, R; Shanthakumari, S; Subbarao, TM; Thara, S; Theresa, R, 2004)
"Biopsy-confirmed high-grade cervical cancer precursor lesions and cancer at 6 and 12 months in the HPV DNA and VIA groups compared with the delayed evaluation (control) group; complications after cryotherapy."	2.71	Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. ( De Souza, M; Denny, L; Dupree, W; Kuhn, L; Pollack, AE; Wright, TC, 2005)
"HPV testing is the preferred method for cervical cancer screening."	2.66	Screening and management of preinvasive lesions of the cervix: Good clinical practice recommendations from the Federation of Obstetrics and Gynaecologic Societies of India (FOGSI). ( Basu, P; Bhalerao, S; Bhatla, N; Chavan, N; Purandare, CN; Saraiya, U; Shamsunder, S; Singhal, S; Srivastava, S, 2020)
"The number of cervical cancer screening implementation reports is limited globally, especially in low-income countries."	2.66	Evaluating the implementation of cervical cancer screening programs in low-resource settings globally: a systematized review. ( Demment, M; Dye, T; Dykens, JA; Irwin, T; Marshall, E; McIntosh, S; Peters, K; Schuh, T; Smith, JS; Sy, A, 2020)
"Articles reporting results from cervical cancer screening programs in community-based settings, conducted in India, and using VIA were included in this review."	2.55	Implementing community-based cervical cancer screening programs using visual inspection with acetic acid in India: A systematic review. ( Adsul, P; Arun, A; Madhivanan, P; Manjunath, N; Srinivas, V, 2017)
"Cervical cancer is the fourth most common cancer among women worldwide."	2.53	Cervical Cancer Screening in Developing Countries: Using Visual Inspection Methods. ( Ju, W; Kang, Y; Lee, H, 2016)
"India alone bears 23% of the global cervical cancer burden."	2.53	Prevention of Cervix Cancer in India. ( Mishra, GA; Pimple, SA; Shastri, SS, 2016)
"Cervical cancer is the fourth most common cancer among women globally and the second most common cancer among Indian women."	2.53	Prevention of Cervix Cancer in India. ( Mishra, GA; Pimple, SA; Shastri, SS, 2016)
"Nine of 10 deaths from cervical cancer occur in low- and middle-income countries (LMICs)."	2.52	A systematic review of the effects of visual inspection with acetic acid, cryotherapy, and loop electrosurgical excision procedures for cervical dysplasia in HIV-infected women in low- and middle-income countries. ( Forhan, SE; Godfrey, CC; Langley, CL; Watts, DH, 2015)
"Pooled sensitivity and specificity were similar for HPV testing versus VIA (both P ≥ 0."	2.52	Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. ( Combescure, C; Fokom-Defo, V; Fokom-Domgue, J; Kengne, AP; Petignat, P; Tebeu, PM; Vassilakos, P, 2015)
"For primary screening of cervical cancer in sub-Saharan Africa, VILI is a simple and affordable alternative to cytology that demonstrates higher sensitivity than VIA."	2.52	Performance of alternative strategies for primary cervical cancer screening in sub-Saharan Africa: systematic review and meta-analysis of diagnostic test accuracy studies. ( Combescure, C; Fokom-Defo, V; Fokom-Domgue, J; Kengne, AP; Petignat, P; Tebeu, PM; Vassilakos, P, 2015)
"Approximately 88% of cervical cancer cases are diagnosed in low-resource countries, yet very few resources are allocated to prevention and treatment programs."	2.49	Cervical cancer screening and prevention in low-resource settings. ( Bradford, L; Goodman, A, 2013)
"Cervical cancer is both preventable and curable, yet it remains one of the leading causes of mortality in women worldwide."	2.49	Cervical cancer screening and prevention in low-resource settings. ( Bradford, L; Goodman, A, 2013)
"Cervical cancer has been considered an AIDS-defining illness, with HPV and HIV often coexisting, and screening methods have been shown to be as reliable for women with HIV as those without."	2.48	Cervical cancer screening in high- and low-resource countries: implications and new developments. ( Dunton, C; Hoppenot, C; Stampler, K, 2012)
"Screening for cervical cancer is well established in resourced countries, but in resource-constrained countries, it is almost non-existent at national level."	2.47	Cervical screening strategies in resourced and resource-constrained countries. ( Cronjé, HS, 2011)
"Cervical cancer is one of the few highly preventable cancers."	2.47	Role of VIA in cervical cancer screening in low-resource countries. ( Begum, N; Hossain, F; Nahar, KN; Nasrin, B; Nessa, A; Shamim, S, 2011)
"VIA may be incorporated in cervical cancer screening programme in low resource setting country because of high negative predictive value of the test is sufficiently high to assure screening for negative and CIN I women."	2.46	Accuracy of visual inspection with acetic acid (VIA) for cervical cancer screening: a systematic review. ( Sritipsukho, P; Thaweekul, Y, 2010)
"Although one-third of the world cervical cancer burden is endured in India, Bangladesh, Nepal and Sri Lanka, there are important gaps in our knowledge of the distribution and determinants of the disease in addition to inadequate investments in screening, diagnosis and treatment in these countries."	2.44	Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. ( Ariyaratne, Y; Ashrafunnessa, KS; Basu, P; Bhatla, N; Esmy, PO; Gravitt, PE; Nene, BM; Sankaranarayanan, R; Shah, A, 2008)
"Cervical cancer is a relatively neglected disease in terms of advocacy, screening and prevention from professional or public health organizations."	2.44	Human papillomavirus infection and cervical cancer prevention in India, Bangladesh, Sri Lanka and Nepal. ( Ariyaratne, Y; Ashrafunnessa, KS; Basu, P; Bhatla, N; Esmy, PO; Gravitt, PE; Nene, BM; Sankaranarayanan, R; Shah, A, 2008)
"The modern approach to cervical cancer prevention, characterized by use of cytology and multiple visits for diagnosis and treatment, has frequently proven challenging and unworkable in low-resource settings."	2.43	Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy. ( Blumenthal, PD; Lauterbach, M; Sankaranarayanan, R; Sellors, JW, 2005)
"Screening programmes for cervical cancer using the current test--the Pap smear--have markedly reduced the incidence of the disease."	2.42	Translational approaches to improving cervical screening. ( Baldwin, P; Coleman, N; Laskey, R, 2003)
"Because the burden of cervical cancer is highest in such low-resource settings, alternative techniques have been sought."	2.42	Performance of visual inspection with acetic acid for cervical cancer screening: a qualitative summary of evidence to date. ( Blumenthal, PD; Gaffikin, L; Lauterbach, M, 2003)
"Cervical cancer is the most common female cancer in Eastern Africa, and the World Health Organization (WHO) recommends human papillomavirus (HPV)-based screening as a key element to eliminate the disease."	1.91	Comparison of human papillomavirus-based cervical cancer screening strategies in Tanzania among women with and without HIV. ( Iftner, T; Kahesa, C; Katanga, J; Kjaer, SK; Kjaerem, M; Linde, DS; Manongi, R; Mchome, B; Mwaiselage, J; Rasch, V; Swai, P; Thomsen, LT; Waldstrøm, M, 2023)
"The study found high rates of hrHPV infection, particularly in HIV-positive women, with many concurrent or multiple infections."	1.91	Screening approaches for cervical cancer in Mozambique in HIV positive and negative women. ( Bicho, C; Carrilho, C; Catalao, C; Ceffa, S; Ciccacci, F; Fonseca, AM; Guidotti, G; Lorenzoni, C; Marazzi, MC; Massango, C; Orlando, S; Parruque, F; Rangeiro, R; Sineque, A, 2023)
"Globally, cervical cancer is a major public health problem, with about 604,000 new cases and over 340,000 deaths in 2020."	1.91	Integrating human papillomavirus testing as a point-of care service using GeneXpert platforms: Findings and lessons from a Kenyan pilot study (2019-2020). ( Arbyn, M; Bor, JP; Mwenda, V; Njeru, J; Njiri, P; Nyangasi, M; Olwande, S; Temmerman, M; Tummers, P; Weyers, S, 2023)
"We evaluated cervical cancer program for women living with HIV (WLHIV) to determine program screening rate, primary case finder screening accuracy and treatment and post-treatment screening rate among screen-positive patients."	1.91	Cervical cancer screening and treatment for PLWHIV: experiences from an innovative program in Nigeria. ( Ajayi, OA; Akinro, Y; Amoo, B; Ayoka-Ikechukwu, R; Ifechelobi, C; Ogunsola, OO; Ojo, TO; Okonkwo, P; Olumeyan, OO; Osayi, E; Wudiri, K, 2023)
"A ten-month review of cervical cancer program data among WLHIV aged 15-49 years on HIV care across forty-one comprehensive ART sites, supported by APIN (a PEPFAR implementing partner) for cervical cancer screening and treatment in Nigeria, was conducted from October 2020 to July 2021."	1.91	Cervical cancer screening and treatment for PLWHIV: experiences from an innovative program in Nigeria. ( Ajayi, OA; Akinro, Y; Amoo, B; Ayoka-Ikechukwu, R; Ifechelobi, C; Ogunsola, OO; Ojo, TO; Okonkwo, P; Olumeyan, OO; Osayi, E; Wudiri, K, 2023)
"This innovative approach to cervical cancer screening among WLHIV yielded modest results in preventing program error and wastages."	1.91	Cervical cancer screening and treatment for PLWHIV: experiences from an innovative program in Nigeria. ( Ajayi, OA; Akinro, Y; Amoo, B; Ayoka-Ikechukwu, R; Ifechelobi, C; Ogunsola, OO; Ojo, TO; Okonkwo, P; Olumeyan, OO; Osayi, E; Wudiri, K, 2023)
"However, screening for cervical cancer is still underused particularly in rural areas of Burkina Faso."	1.91	Cervical pre-cancer screening by visual inspection of the cervix after application of acetic acid in rural Burkina Faso: evaluation of women's knowledge, screening practice habits, acceptability and prevalence of risk factors and lesions in Boussé health ( Meda, N; Ouattara, A; Sawadogo, M; Tassembedo, S; Traore, IT; Winter, CH, 2023)
"cervical cancer is a major public health problem among women in sub-Saharan Africa."	1.91	Cervical pre-cancer screening by visual inspection of the cervix after application of acetic acid in rural Burkina Faso: evaluation of women's knowledge, screening practice habits, acceptability and prevalence of risk factors and lesions in Boussé health ( Meda, N; Ouattara, A; Sawadogo, M; Tassembedo, S; Traore, IT; Winter, CH, 2023)
"Cervical cancer is the fourth most common cancer in women worldwide."	1.91	Correlation between Knowledge, Attitude, and Partner Support Towards Visual Inspection with Acetic Acid Test among Women in Denpasar City, Indonesia. ( Paramitha, PP; Winata, IGS; Yusrika, MU, 2023)
"Cervical cancer is the third most common malignancy in women globally."	1.91	Midwives as the Primary Care Providers: Knowledge, Attitude, Practice, and Skill of Early Detection of Cervical Cancer Using Visual Inspection with Acetic Acid. ( Paramitha, PP; Winata, IGS; Yusrika, MU, 2023)
"Only 1% of women reported prior cervical cancer screening."	1.91	The CryoPop study: Screening for high-grade cervical dysplasia in Karnataka, India. ( Anderson, JR; Antartani, R; Bidri, S; Chikaraddi, S; Dalal, A; Derman, R; Donimath, K; Goudar, SS; Gudadinni, MR; Lokare, L; Lu, E; Mensa, M; Patil, B; Thaler, K; Yenokyan, G; Yogeshkumar, S, 2023)
"Zimbabwe has high cervical cancer (CC) burden of 19% and mortality rate of 64%."	1.91	Prevalence of Cervical Cancer and Clinical Management of Women Screened positive using visual inspection with acetic acid and Cervicography in selected public sector health facilities of Manicaland and Midlands provinces of Zimbabwe, 2021. ( Chingombe, B; Dhodho, M; Dube, S; Ganje, N; Maravanyika, A; Mhangara, M; Muchedzi, A; Mukungunugwa, S; Mupanguri, C; Muzondo, M; Nyamundaya, T; Samushonga, T; Sibanda, TP; Tachiwenyika, E; Tafuma, T; Tapera, T, 2023)
" Patients were followed up at 6 weeks for any complication and reassessed by VIA and colposcopy at 12 months for any persistent or recurrent lesion and for any adverse event."	1.72	Evaluation of effectiveness, acceptability and safety of thermal ablation in the treatment of cervical neoplasia in Burundi. ( Barango, P; Bazikamwe, S; Harerimana, S; Lucas, E; Ndayikengurukiye, A; Sauvaget, C, 2022)
"All women who underwent cervical cancer screening using visual inspection with acetic acid between June 2017 to December 2018 were included."	1.72	Community-Based Cervical Cancer Screening using Visual Inspection with Acetic Acid. ( Dawadi, T; Mulmi, R; Pathak, A; Pradhananga, KK; Sharma, M; Shrestha, G; Siwakoti, B, 2022)
"Cervical cancer is the most common cancer among Nepalese women."	1.72	Community-Based Cervical Cancer Screening using Visual Inspection with Acetic Acid. ( Dawadi, T; Mulmi, R; Pathak, A; Pradhananga, KK; Sharma, M; Shrestha, G; Siwakoti, B, 2022)
"Cervical cancer was suspected in 25 (0."	1.72	Community-Based Cervical Cancer Screening using Visual Inspection with Acetic Acid. ( Dawadi, T; Mulmi, R; Pathak, A; Pradhananga, KK; Sharma, M; Shrestha, G; Siwakoti, B, 2022)
"Although cervical cancer is a preventable disease, screening coverage in Ethiopia is far below the target."	1.62	Cervical cancer screening "see and treat approach": real-life uptake after invitation and associated factors at health facilities in Gondar, Northwest Ethiopia. ( Addissie, A; Destaw, A; Gizaw, M; Kantelhardt, EJ; Midaksa, M, 2021)
"Cancer of the uterine cervix is one of the leading causes of mortality and morbidity among women in poor countries."	1.62	"Screen and Treat" Approach among VIA Positive Women during Cervical Cancer Screening Program: Experience at Low Resource Setting. ( Akhter, R; Begum, KN; Hira, HM; Shahnaz, S; Sharmin, S, 2021)
"During a July 2018 cervical cancer screen-and-treat in Mwanza, Tanzania, participants were offered free cervical VIA screening, cryotherapy when indicated, and HIV testing."	1.62	Visual inspection with acetic acid screening for cervical cancer among women receiving anti-retroviral therapy for human immunodeficiency virus infection in northern Tanzania. ( Bera, KR; Bernstein, M; Chang, J; Chinn, JO; Cooper, EC; Crawford, EW; Dinicu, AI; Hari, A; Lucas, AN; Maher, JA; Naaseh, A; Pearre, DC; Runge, AS; Tewari, KS; Tewari, SE; White, KM; Zezoff, DC; Ziogas, A, 2021)
"Background: Cervical cancer is the fourth most common cancer among women in the world."	1.62	Women's Knowledge, Attitude and Practice on Cervical Cancer and Its Screening in Dhaka, Bangladesh. ( Akhter, R; Billah, MM; Flora, MS; Qayum, MO, 2021)
"WHO recommendation for cervical cancer screening in LMICs includes HPV testing as primary screening followed by visual inspection with acetic acid (VIA) and treatment."	1.62	Study protocol for a two-site clinical trial to validate a smartphone-based artificial intelligence classifier identifying cervical precancer and cancer in HPV-positive women in Cameroon. ( Baleydier, I; Cattin, M; Enownchong Enow Orock, G; Foguem Tincho, E; Gervaix, A; Kenfack, B; Lemoupa Makajio, S; Makohliso, S; Petignat, P; Schönenberger, K; Thiran, JP; Tsuala Fouogue, J; Undurraga, M; Vassilakos, P; Viñals, R; Wisniak, A, 2021)
"cervical cancer is more prevalent in the developing world affecting mainly women in the reproductive age group and is the commonest cancer among Zambian women."	1.62	Cervical cancer and precancerous cervical lesions detected using visual inspection with acetic acid at Livingstone Teaching Hospital. ( Hamooya, BM; Hangoma, J; Hayumbu, V; Malumani, M; Masenga, SK, 2021)
"Cervical cancer is an important public health problem in Thailand."	1.62	National Cervical Cancer Screening in Thailand. ( Jamsri, P; Pangmuang, P; Ploysawang, P; Prapakorn, S; Rojanamatin, J; Sangrajrang, S; Seeda, K, 2021)
"Globally, the highest cervical cancer mortality rates are found in East Africa."	1.62	Downstaging of cervical cancer in Tanzania over a 16-year period. ( Gard, AC; Kahesa, C; Mattick, LJ; Mwaiselage, J; Ochs-Balcom, HM; Shalan, F; Soliman, AS, 2021)
" Thermal ablation is a safe and effective alternative to cryotherapy."	1.62	Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi. ( Chapola, J; Chinula, L; Gopal, S; Hosseinipour, M; Limarzi, L; Mapanje, C; Stanley, C; Tang, JH; Topazian, HM; Varela, A, 2021)
"Malawi has the highest invasive cervical cancer (ICC) mortality rate worldwide, and ICC is the leading cause of cancer death among women."	1.62	Uptake and safety of community-based "screen-and-treat" with thermal ablation preventive therapy for cervical cancer prevention in rural Lilongwe, Malawi. ( Chapola, J; Chinula, L; Gopal, S; Hosseinipour, M; Limarzi, L; Mapanje, C; Stanley, C; Tang, JH; Topazian, HM; Varela, A, 2021)
"Visual inspection methods for cervical cancer screening are widely used in low resource settings."	1.62	Diagnostic Accuracy of Fluorescein Sodium for Targeted Cervical Biopsies. ( Bhati, P; Chandy, RG; Mani, T; Moein, S; Peedicayil, A; Sebastian, A; Thomas, A, 2021)
"Approximately 90% of global cervical cancer (CC) is mostly found in low- and middle-income countries."	1.56	Quantitative Screening of Cervical Cancers for Low-Resource Settings: Pilot Study of Smartphone-Based Endoscopic Visual Inspection After Acetic Acid Using Machine Learning Techniques. ( Ahn, Y; Askaruly, S; Bae, JK; Jang, GJ; Jung, W; Kim, K; Moon, KH; Park, K; Roh, HJ; Yang, H; You, JS, 2020)
"Cervical cancer is the second most common cancer in Ethiopia next to breast cancer."	1.56	Factors affecting cervical cancer screening uptake, visual inspection with acetic acid positivity and its predictors among women attending cervical cancer screening service in Addis Ababa, Ethiopia. ( Fentie, AM; Gebretekle, GB; Tadesse, TB, 2020)
"Screening for cervical cancer is primarily conducted using visual inspection with 5% acetic acid (VIA)."	1.56	Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia. ( Abdissa, A; Ahmed, Y; Dube, L; Eshetu, K; Gedefaw, L; Goba, G; Godu, S; Hailekiros, H; Joloba, M; Nigussie, M; Tesfaw, G, 2020)
"Cervical cancer is the second leading type of female cancer in Ethiopia."	1.56	Liquid-based cytology for the detection of cervical intraepithelial lesions in Jimma town, Ethiopia. ( Abdissa, A; Ahmed, Y; Dube, L; Eshetu, K; Gedefaw, L; Goba, G; Godu, S; Hailekiros, H; Joloba, M; Nigussie, M; Tesfaw, G, 2020)
"Worldwide cervical cancer is the third most common malignancy in women."	1.56	Magnitude and associated factors of VIA positive test results for cervical cancer screening among refugee women aged 25-49 years in North Ethiopia. ( Gebrecherkos, K; Gebregyorgis, T; Gebreyesus, H; Hailemariam, G; Kifle, M; Teweldemedhin, M; Wubayehu, T, 2020)
"Previous history of sexually transmitted infections (STI) [AOR (95%CI) = 2."	1.56	Magnitude and associated factors of VIA positive test results for cervical cancer screening among refugee women aged 25-49 years in North Ethiopia. ( Gebrecherkos, K; Gebregyorgis, T; Gebreyesus, H; Hailemariam, G; Kifle, M; Teweldemedhin, M; Wubayehu, T, 2020)
"Previous history of sexually transmitted infections (STI) and presence of STI during cervical examination were found associated with VIA positive precancerous cervical lesions."	1.56	Magnitude and associated factors of VIA positive test results for cervical cancer screening among refugee women aged 25-49 years in North Ethiopia. ( Gebrecherkos, K; Gebregyorgis, T; Gebreyesus, H; Hailemariam, G; Kifle, M; Teweldemedhin, M; Wubayehu, T, 2020)
"Incidence and mortality related to cervical cancer both have declining in developed countries because of effective screening programs through Papanicolaou smear."	1.56	Evaluation of Visual Inspection of Cervix with Acetic Acid and Liquid Based in Cervical Cancer Screening with Cervical Biopsy. ( Joshi, R; Malla Vaidya, K; Shrestha, B, 2020)
"Cervical cancer is the second most common cancer among women in developing countries."	1.56	Evaluation of Visual Inspection of Cervix with Acetic Acid and Liquid Based in Cervical Cancer Screening with Cervical Biopsy. ( Joshi, R; Malla Vaidya, K; Shrestha, B, 2020)
"Cervical cancer is a major contributor to mortality and morbidity in women."	1.56	Comparative Study of Smart Scope® Visual Screening Test with Naked Eye Visual Screening and Pap Test. ( Oka, G; Rahatgaonkar, V; Uchale, P, 2020)
"In Tanzania, the incidence of cervical cancer is nearly ten times that found in the US."	1.51	Development and Implementation of a Culturally Appropriate Education Program to Increase Cervical Cancer Screening among Maasai Women in Rural Tanzania. ( Dougherty, A; Jorgensen, J; Lidofsky, A; Mallange, E; Miller, A; Pius, D; Tajik, A; Tendeu, K, 2019)
"Direct visual inspection for cervical cancer screening remains controversial, whereas colposcopy-biopsy is considered the gold standard for diagnosis of preneoplastic cervical lesions."	1.51	Visual techniques for cervical cancer screening in Colombia ( Bonilla, J; Gamboa, Ó; González, M; Inc, CCSSG; Luna, J; Murillo, R, 2019)
"Cervical cancer is a major public health problem especially in developing countries."	1.51	Evaluation of Abnormal Cervix with Visual Inspection under Acetic Acid and Colposcopy. ( Bajracharya, N; Bhattachan, K; Dangal, G; Karki, A; Parajuli, S; Poudel, R; Pradhan, HK; Shrestha, R; Tiwari, K, 2019)
"Cervical cancer is the tenth most frequent cancer in Egyptian women."	1.51	Screening of Cervical Cancer: Visual Inspection with Acetic Acid (VIA) and Site of Lesion Verified by Multiple Punch Biopsies. ( Abd El-Fattah, NH; Gad, MM; Galal, SB; Helmy, W, 2019)
"Over 50% (7."	1.51	Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon. ( Cumber, SN; Mubah, TM; Nkfusai, NC; Tambe, TA; Yankam, BM, 2019)
"Cervical cancer is the second most prevalent cancer among women in the developing countries including Ethiopia."	1.48	Factors associated with cervical precancerous lesions among women screened for cervical cancer in Addis Ababa, Ethiopia: A case control study. ( Addissie, A; Ayele, W; Gebreheat, G; Gebremariam, A; Hirpa, S; Jemal, A; Teame, H, 2018)
" Cervical cancer is the fourth most common cancer worldwide among women, with the number of new cases increasing from 493 243 in 2002 to 527 000 in 2012."	1.48	Distribution of cervical abnormalities detected by visual inspection with acetic acid in Swaziland, 2011-2014: A retrospective study. ( Almonte, M; Dlamini, X; Ginindza, TG; Sartorius, B, 2018)
"Malawi has the highest rate of cervical cancer globally and cervical cancer is six to eight times more common in women with HIV."	1.48	Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi. ( Akello, H; Amberbir, A; Banda, V; Berman, J; Kabeya, BM; Kwekwesa, A; Matengeni, A; Msonko, J; Pfaff, C; Singano, V; Speight, C; van Oosterhout, JJ, 2018)
"In October 2015, a model of integrated cervical cancer screening using visual inspection with acetic acid (VIA) was adopted."	1.48	Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi. ( Akello, H; Amberbir, A; Banda, V; Berman, J; Kabeya, BM; Kwekwesa, A; Matengeni, A; Msonko, J; Pfaff, C; Singano, V; Speight, C; van Oosterhout, JJ, 2018)
"Between May 2016 and March 2017, cervical cancer screening was performed in 957 women from the HIV clinic."	1.48	Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi. ( Akello, H; Amberbir, A; Banda, V; Berman, J; Kabeya, BM; Kwekwesa, A; Matengeni, A; Msonko, J; Pfaff, C; Singano, V; Speight, C; van Oosterhout, JJ, 2018)
"Incorporating cervical cancer screening into services at HIV clinics is feasible."	1.48	Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi. ( Akello, H; Amberbir, A; Banda, V; Berman, J; Kabeya, BM; Kwekwesa, A; Matengeni, A; Msonko, J; Pfaff, C; Singano, V; Speight, C; van Oosterhout, JJ, 2018)
"To assess the implementation of a cervical cancer screening strategy in rural Madagascar."	1.46	[Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence]. ( Benbassa, A; Bessières, N; Dumont, A; Philippe, HJ; Rabearison, F; Razafindrafara, G, 2017)
"When a cervical cancer screening by HPV or cytology is not possible, VIA remains a feasible and acceptable option in a disadvantaged environment."	1.46	[Cervical cancer screening in rural Madagascar: Feasibility, coverage and incidence]. ( Benbassa, A; Bessières, N; Dumont, A; Philippe, HJ; Rabearison, F; Razafindrafara, G, 2017)
"Population cervical cancer prevention using VIA plus immediate cryotherapy leads to significant reduction in the population prevalence of cervical SIL."	1.46	Impact of visual inspection with acetic acid plus cryotherapy "see and treat" approach on the reduction of the population burden of cervical preinvasive lesions in Southeast Nigeria. ( Chigbu, CO; Egbuji, CC; Nnakenyi, EF; Onyebuchi, AK, 2017)
"Cervical cancer is the most common cancer in Sub-Saharan Africa."	1.43	Prospective One Year Follow Up of HIV Infected Women Screened for Cervical Cancer Using Visual Inspection with Acetic Acid, Cytology and Human Papillomavirus Testing in Johannesburg South Africa. ( Allan, B; Faesen, M; Firnhaber, C; Goeieman, B; Levin, S; Michelow, P; Omar, T; Rameotshela, S; Schnippel, K; Smith, JS; Swarts, A; Williams, S; Williamson, AL, 2016)
"Cervical cancer is the leading cause of morbidity and mortality of women from cancer in the developing World."	1.43	Visual inspection with acetic acid and Lugol's iodine in cervical cancer screening at the general referral hospital Kayembe in Mbuji-Mayi, Democratic Republic of Congo. ( Desire, BK; Félix, KW; Oscar, LN; Philippe, CM; Prosper, KL; Thierry, K; Wembodinga, GU, 2016)
"Cervical cancer is the second most common cause of cancer related morbidity and mortality in women with 50% mortality rate."	1.43	Detection of Cervical Cancer through Visual Inspection of Cervix with Acetic Acid (VIA) and Colposcopy at Mymensingh Medical College Hospital. ( Akhter, SN; Alam, MJ; Banu, S; Bashar, A; Rahman, MF; Sarker, AS; Uddin, MJ, 2016)
"All participants were screened for cervical cancer by Pap smear and VIA."	1.43	Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital. ( Bhamarapravatana, K; Leaungsomnapa, Y; Lertcharernrit, J; Sananpanichkul, P; Suknikhom, W; Suwannarurk, K, 2016)
"Cervical cancer is the second most common in Thailand, but the mortality rate may be rising yearly."	1.43	Prevalence and Risk Assessment of Cervical Cancer Screening by Papanicolaou Smear and Visual Inspection with Acetic Acid for Pregnant Women at a Thai Provincial Hospital. ( Bhamarapravatana, K; Leaungsomnapa, Y; Lertcharernrit, J; Sananpanichkul, P; Suknikhom, W; Suwannarurk, K, 2016)
"The trend of cervical cancer in Thailand is decreasing, one key factor in making this possible was the employment of dual tract strategy (Pap smear and visual inspection with acetic acid [VIA]) by the government in 2005."	1.43	The epidemiologic status of gynecologic cancer in Thailand. ( Lertchaipattanakul, N; Wilailak, S, 2016)
"Quality assurance of a cervical cancer screening program is a key element to ensure that the providers perform VIA correctly and confidently."	1.43	Evaluation of Provider Skills in Performing Visual Inspection with Acetic Acid in the Cervical Cancer Screening Program in the Meknes-Tafilalet Region of Morocco. ( Basu, P; Muwonge, R; Plaza, CA; Rhazi, KE; Sankaranarayanan, R; Sauvaget, C; Selmouni, F; Zidouh, A, 2016)
"Women enrolled in HIV care at the Family AIDS Care and Education Services clinic in Kisumu, Kenya, were recruited for participation."	1.42	Accuracy of visual inspection with acetic acid to detect cervical cancer precursors among HIV-infected women in Kenya. ( Abdulrahim, N; Bukusi, EA; Cohen, CR; Huchko, MJ; Maloba, M; Sawaya, G; Smith-McCune, K; Sneden, J, 2015)
"Eligible women were counseled about cervical cancer and how to perform self-sampling."	1.42	Effectiveness of a two-stage strategy with HPV testing followed by visual inspection with acetic acid for cervical cancer screening in a low-income setting. ( Catarino, R; Crofts, V; Flahaut, E; Fokom-Domgue, J; Petignat, P; Tebeu, PM; Untiet, S; Vassilakos, P, 2015)
"To estimate the long-term risk of cervical cancer among women screened by visual inspection with acetic acid (VIA) and to evaluate the benefit of additional colposcopy triage in rural south India."	1.42	Risk of invasive cancer among women visually screened and colposcopy triaged by trained nurses in rural South India. ( Esmy, PO; Hakama, M; Malila, N; Muwonge, R; Sankaranarayanan, R; Thulaseedharan, JV, 2015)
"The prevalence of HR-HPV infection among all enrolled women was 11."	1.42	Evaluation of several screening approaches for detection of cervical lesions in rural Shandong, China. ( Cui, BX; Jiang, J; Jiang, K; Kong, BH; Li, L; Qiao, YB; Shen, K; Yang, XS; Zhang, WJ; Zhang, YZ; Zong, LJ, 2015)
"Opportunistic cervical cancer screening is a practical approach to improve the efficiency of cervical cancer screening."	1.42	Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening? ( Eurasian, M; Gao, K; Li, L; Wei, Y; Ye, H; Zhang, J; Zheng, Q, 2015)
"In a public sector cervical cancer prevention program in Zambia, nurses provided visual-inspection with acetic acid (VIA) and cryotherapy in clinics co-housed with HIV/AIDS programs, and referred women with complex lesions for histopathologic evaluation."	1.42	Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. ( Bateman, AC; Blevins, M; Chi, BH; Chibwesha, CJ; Chisele, S; Hicks, ML; Kapambwe, S; Mkumba, G; Mudenda, V; Muwonge, R; Mwanahamuntu, MH; Parham, GP; Pfaendler, KS; Sahasrabuddhe, VV; Sankaranarayanan, R; Shibemba, AL; Stringer, JS; Vermund, SH; Vwalika, B, 2015)
"Detection rates for CIN2+ and invasive cervical cancer were 17 and 7 per 1,000 women screened, respectively."	1.42	Population-level scale-up of cervical cancer prevention services in a low-resource setting: development, implementation, and evaluation of the cervical cancer prevention program in Zambia. ( Bateman, AC; Blevins, M; Chi, BH; Chibwesha, CJ; Chisele, S; Hicks, ML; Kapambwe, S; Mkumba, G; Mudenda, V; Muwonge, R; Mwanahamuntu, MH; Parham, GP; Pfaendler, KS; Sahasrabuddhe, VV; Sankaranarayanan, R; Shibemba, AL; Stringer, JS; Vermund, SH; Vwalika, B, 2015)
"Cervical cancer is the commonest cancer amongst African women, and yet preventative services are often inadequate."	1.42	Cervical cancer screening: Safety, acceptability, and feasibility of a single-visit approach in Bulawayo, Zimbabwe. ( Fallala, MS; Mash, R, 2015)
"Over 85% of cervical cancer cases and deaths occur in low-resource countries."	1.42	Cancer of the cervix: Early detection and cost-effective solutions. ( Denny, L; Prendiville, W, 2015)
"Cervical cancer is known to be a preventable disease through the detection of cervical cancer precursors, historically using cytology of the cervix as the primary screening test."	1.42	Cancer of the cervix: Early detection and cost-effective solutions. ( Denny, L; Prendiville, W, 2015)
"Thus, any cervical cancer prevention and control effort at the study area should address the problem of early initiation of sexual intercourse."	1.42	Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study. ( Deksissa, ZM; Ferede, HA; Tesfamichael, FA, 2015)
"Cervical cancer is the 2nd most frequent and top killer cancer among women in Ethiopia."	1.42	Prevalence and factors associated with VIA positive result among clients screened at Family Guidance Association of Ethiopia, south west area office, Jimma model clinic, Jimma, Ethiopia 2013: a cross-sectional study. ( Deksissa, ZM; Ferede, HA; Tesfamichael, FA, 2015)
"However, cervical cancer is largely preventable when early screening and treatment are available."	1.42	Costs and Cost Effectiveness of Three Approaches for Cervical Cancer Screening among HIV-Positive Women in Johannesburg, South Africa. ( Firnhaber, C; Lince-Deroche, N; Michelow, P; Phiri, J; Smith, JS, 2015)
"Cervical cancer is the second commonest type and third cause of cancer death among women in low-income countries."	1.42	DETERMINANT FACTORS OF VISUAL INSPECTION WITH ACETIC ACID (VIA) POSITIVE LESIONS AMONG HIV POSITIVE WOMEN IN MEKELLE HOSPITAL, NORTHERN ETHIOPIA: A CASE CONTROL STUDY. ( Alemayehu, M; Derbew, M; Eva, K; Gessesse, Z; Getachew, Y; Hiruye, A; Mammo, D; Mariam, DH; Michael, HG; Tadesse, Z; Yebyo, H, 2015)
"They were screened for cervical cancer with the use of visual inspection of the cervix after application of 5 % acetic acid (VIA)."	1.40	Prevalence of cervical intraepithelial neoplasia (CIN) in patients attending Minia Maternity University Hospital. ( Hasan, MM; Kamel, HH; Sanad, AS, 2014)
"Cervical cancer is the second most common cancer of the genital tract."	1.40	Prevalence of cervical intraepithelial neoplasia (CIN) in patients attending Minia Maternity University Hospital. ( Hasan, MM; Kamel, HH; Sanad, AS, 2014)
"In see-and-treat VIA-based cervical cancer prevention programs in low-resource countries, visual LEEP can be used to treat women who do not meet the criteria for ablative treatment."	1.40	Use of a portable diathermy machine for LEEP without colposcopy during see-and-treat management of VIA-positive cervical lesions in resource-poor settings. ( Chigbu, CO; Onyebuchi, AK, 2014)
"To determine the optimal strategy for cervical cancer screening in women with human immunodeficiency virus (HIV) infection by comparing two strategies: visual inspection of the cervix with acetic acid (VIA) and VIA followed immediately by visual inspection with Lugol's iodine (VIA/VILI) in women with a positive VIA result."	1.40	A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. ( Abdulrahim, N; Bukusi, E; Cohen, CR; Huchko, MJ; Leslie, HH; Maloba, M; Sneden, J, 2014)
"Data from a cervical cancer screening programme embedded in two HIV clinic sites in western Kenya were evaluated."	1.40	A comparison of two visual inspection methods for cervical cancer screening among HIV-infected women in Kenya. ( Abdulrahim, N; Bukusi, E; Cohen, CR; Huchko, MJ; Leslie, HH; Maloba, M; Sneden, J, 2014)
"To evaluate a cervical cancer prevention project in Guyana utilizing visual inspection with acetic acid (VIA) and immediate cryotherapy in a single-visit approach; and to identify lessons learned to inform the improvement of cervical cancer prevention programs in Guyana and other low-resource settings."	1.40	Evaluation of a single-visit approach to cervical cancer screening and treatment in Guyana: feasibility, effectiveness and lessons learned. ( Estep, D; Martin, CE; Reinsel, M; Tergas, AI; Varallo, J; Wysong, M, 2014)
" HPV testing on a self-sample positive combined with VIA increases specificity to 98."	1.40	HPV detection in a self-collected vaginal swab combined with VIA for cervical cancer screening with correlation to histologically confirmed CIN. ( El Behery, MM; El Sayed, GA; El Shennawy, GA; Kamal, EM, 2014)
"The second means of cervical cancer prevention is visual inspection of the cervix uteri with acetic acid, while often both methods are combined."	1.39	Influence of acetic acid on a pap smear of dysplastic lesion. ( Bohlmann, MK; Brade, J; Diedrich, K; Hoellen, F; Hornemann, A; Husstedt, WD; Rody, A, 2013)
"Cervical cancer is preventable but continues to cause the deaths of more than 270,000 women worldwide each year, most of them in developing countries where programs to detect and treat precancerous lesions are not affordable or available."	1.39	Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam. ( Bartolini, RM; Huong, TT; Jeronimo, J; Kumakech, E; Mugisha, E; Nga, le T; Paul, P; Penny, ME; Winkler, JL, 2013)
"Cervical cancer is preventable but continues to cause the deaths of more than 270,000 women worldwide each year, most of them in developing countries where programs to detect and treat precancerous lesions are not affordable or available."	1.39	Screen-and-treat approach to cervical cancer prevention using visual inspection with acetic acid and cryotherapy: experiences, perceptions, and beliefs from demonstration projects in Peru, Uganda, and Vietnam. ( Bartolini, RM; Huong, TT; Jeronimo, J; Kumakech, E; Mugisha, E; Nga, le T; Paul, P; Penny, ME; Winkler, JL, 2013)
"However, variable sensitivity and specificity have been observed in various community based studies."	1.39	Reasons for variation in sensitivity and specificity of visual inspection with acetic acid (VIA) for the detection of pre- cancer and cancer lesions of uterine cervix. ( Parashari, A; Singh, V, 2013)
"Community-based advocacy for cervical cancer screening is a very effective method of creating awareness for cervical cancer screening."	1.39	Motivations and preferences of rural Nigerian women undergoing cervical cancer screening via visual inspection with acetic acid. ( Ajah, LO; Chigbu, CO; Onwudiwe, EN; Onyebuchi, AK, 2013)
"Mexican Cervical Cancer Screening Study II (MECCS II) seeks to develop a highly sensitive and highly specific screening program able to be adapted to all socioeconomic levels in Mexico."	1.39	Primary cervical cancer screening and triage using an mRNA human papillomavirus assay and visual inspection. ( Belinson, J; Belinson, S; Booth, C; Brainard, J; Chávez-Avilés, MN; Chiesa-Vottero, A; Enerson, CL; Nagore, N; Nieves, L; Pérez, AG, 2013)
"Each woman had cervical cancer screening by VIA, liquid-based cytologic test, and oncogenic human papillomavirus (HPV) DNA test."	1.39	A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. ( Adepiti, AC; Ajenifuja, KO; Burk, RD; Eklund, C; Gage, JC; Hutchinson, M; Reilly, M; Schiffman, M; Wentzensen, N, 2013)
"Cervical cancer is the most common gynecological cancer in developing countries."	1.39	A population-based study of visual inspection with acetic acid (VIA) for cervical screening in rural Nigeria. ( Adepiti, AC; Ajenifuja, KO; Burk, RD; Eklund, C; Gage, JC; Hutchinson, M; Reilly, M; Schiffman, M; Wentzensen, N, 2013)
"The age-standardized mortality rate for cervical cancer in Ghana, West Africa is more than three times the global cervical cancer mortality rate (27."	1.38	Knowledge and beliefs about cervical cancer screening among men in Kumasi, Ghana. ( Amoateng, P; Williams, MS, 2012)
"A 2-tier community-based cervical cancer prevention program was implemented."	1.38	Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. ( de Klerk, R; Friedman, HM; Monare, B; Ramogola-Masire, D; Ratshaa, B; Zetola, NM, 2012)
"Our "see and treat" cervical cancer prevention program using the VIA/EDI approach is a feasible, high-output and high-efficiency program, worthy of considering as an additional cervical cancer screening method in Botswana, especially for women with limited access to the current cytology-based screening services."	1.38	Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. ( de Klerk, R; Friedman, HM; Monare, B; Ramogola-Masire, D; Ratshaa, B; Zetola, NM, 2012)
"Cervical cancer is a major public health problem in resource-limited settings, particularly among HIV-infected women."	1.38	Cervical cancer prevention in HIV-infected women using the "see and treat" approach in Botswana. ( de Klerk, R; Friedman, HM; Monare, B; Ramogola-Masire, D; Ratshaa, B; Zetola, NM, 2012)
"Therefore, if multiple cervical cancer screenings are not feasible logistically or financially, a one-time VIA/VILI may be the most efficient strategy to detect cervical cancer and most CIN3 lesions in women in low-resource settings."	1.38	Analysis of the effectiveness of visual inspection with acetic acid/Lugol's iodine in one-time and annual follow-up screening in rural China. ( Hu, SY; Jiang, HW; Lewkowitz, AK; Li, M; Li, R; Qiao, YL; Qiu, H; Tong, SM; Zhang, JS; Zhang, QY; Zhang, Y; Zhao, FH; Zhou, Q, 2012)
"The high burden of cervical cancer and inadequate/suboptimal cytology screening in developing countries led to the evaluation of visual screening tests, like visual inspection with acetic acid (VIA) and Lugol's iodine (VILI)."	1.38	Accuracy of concurrent visual and cytology screening in detecting cervical cancer precursors in rural India. ( Ajit, D; Chinoy, R; Chiwate, A; Deodhar, K; Deshpande, R; Hingmire, S; Jambhekar, N; Jayant, K; Jeronimo, J; Kelkar, R; Malvi, SG; Muwonge, R; Nene, BM; Rekhi, B; Ruben, I; Sankaranarayanan, R; Thorat, R, 2012)
"We nested cervical cancer screening into family planning clinics at select sites also receiving PEPFAR support for antiretroviral therapy (ART) rollout."	1.38	Implementation of cervical cancer screening using visual inspection with acetic acid in rural Mozambique: successes and challenges using HIV care and treatment programme investments in Zambézia Province. ( Baptista, AJ; Cordoso, A; Moon, TD; Sidat, M; Silva-Matos, C; Vermund, SH, 2012)
"To assess acceptability of cervical cancer screening via visual inspection with acetic acid or Lugol's iodine (VIA/VILI) at Mulago Hospital, Uganda."	1.38	Acceptability of cervical cancer screening via visual inspection with acetic acid or Lugol's iodine at Mulago Hospital, Uganda. ( Busingye, P; Mutyaba, T; Nabunya, E; Nakimuli, A, 2012)
"It is the optimal cervical cancer screening strategy to be generalized in our country."	1.38	[Effectiveness and health economic analysis of strategies on cervical cancer screening and early diagnosis and treatment]. ( Chen, JF; Gao, LM; Gao, XH; Hu, SY; Liu, QG; Liu, ZH; Ma, JF; Ma, L; Ning, Y; Qiao, YL; Shi, JF; Xu, H; Xu, XL; Zhao, FH, 2012)
" When choosing between different cervical cancer prevention strategies, the feasibility of increasing uptake to achieve economies of scale should be a major concern."	1.37	Costs of cervical cancer screening and treatment using visual inspection with acetic acid (VIA) and cryotherapy in Ghana: the importance of scale. ( Adu-Sarkodie, Y; Legood, R; Mayaud, P; Opoku, BK; Quentin, W; Terris-Prestholt, F, 2011)
"To evaluate outcomes of cervical cancer screening within HIV care and treatment clinics in Kenya."	1.37	Building capacity for cervical cancer screening in outpatient HIV clinics in the Nyanza province of western Kenya. ( Bukusi, EA; Cohen, CR; Huchko, MJ, 2011)
"Alternative methods for cervical cancer screening have been sought."	1.37	Evaluation of visual inspection with acetic acid as a feasible screening test for cervical neoplasia. ( Esmaeili, H; Hasanzadeh, M; Samadi, F; Tabaee, S, 2011)
"age-specific incidence of HPV infection, progression and regression of the infection, test performance of screening methods and efficacy of vaccine) were synthesized from a systematic review and meta-analysis."	1.37	Economic evaluation of policy options for prevention and control of cervical cancer in Thailand. ( Chichareon, S; Ieumwananonthachai, N; Limwattananon, S; Praditsitthikorn, N; Riewpaiboon, A; Tangcharoensathien, V; Tantivess, S; Teerawattananon, Y, 2011)
"The results suggest that controlling cervical cancer by increasing the numbers of women accepting the VIA and Pap smear screening as routine and by improving the performance of the existing screening programmes is the most cost-effective policy option in Thailand."	1.37	Economic evaluation of policy options for prevention and control of cervical cancer in Thailand. ( Chichareon, S; Ieumwananonthachai, N; Limwattananon, S; Praditsitthikorn, N; Riewpaiboon, A; Tangcharoensathien, V; Tantivess, S; Teerawattananon, Y, 2011)
"Hence VIA and VILI can be used as cervical cancer screening tools in low-resource settings."	1.36	Evaluation of visual inspection with acetic acid and Lugol's iodine as cervical cancer screening tools in a low-resource setting. ( Das, V; Qureshi, S; Zahra, F, 2010)
"The screening coverage of cervical cancer was calculated and the follow-up after finding an abnormal screening result was assessed."	1.36	Barriers to follow-up of abnormal Papanicolaou smears among women in Leon, Nicaragua. ( Bekkers, RL; Castillo, C; Vastbinder, MB, 2010)
"In total, 7145 women received the cervical cancer screening, with a participation rate of 74."	1.36	[Three-year follow-up results of visual inspection with acetic acid/Lugol's iodine (VIA/VILI) used as an alternative screening method for cervical cancer in rural areas]. ( Hu, SY; Ma, JF; Ma, ZH; Qiao, YL; Shi, YT; Xiang, XE; Zhang, YZ; Zhao, FH, 2010)
"The sensitivity and specificity was 70."	1.36	Visual screening for early detection of cervical neoplasia in Angola. ( Dumas, JB; Filipe, AP; Frank, MR; Manuel, Mda G; Muwonge, R; Sankaranarayanan, R, 2010)
"As the single-visit approach for cervical cancer screening gains popularity, more women will have been treated with cryotherapy."	1.36	Cytology versus visual inspection with acetic acid among women treated previously with cryotherapy in a low-resource setting. ( Alonzo, TA; Bullard, K; Cremer, M; Felix, J; Garcia, L; Lerner, V; Masch, R; Maza, M; Moore, E; Peralta, E, 2010)
"The VIA test is a simple method for cervical cancer screening; however, a significant proportion of patients with normal or inflammatory cytology were positive by this test."	1.36	Cervical cancer screening in north east Thailand using the visual inspection with acetic acid (VIA) test and its relationship to high-risk human papillomavirus (HR-HPV) status. ( Chaiwongkot, A; Ekalaksananan, T; Evans, MF; Kongyingyoes, B; Pientong, C; Thinkhamrop, J, 2010)
"Cervical cancer is the most common reproductive cancer in women in Bangladesh, and most women come for diagnosis and treatment when it is too late."	1.35	Development of a visual inspection programme for cervical cancer prevention in Bangladesh. ( Ahmed, T; Rahman, J, 2008)
"This study showed that screening of cervical cancer by visual inspection is workable at CSCOM level."	1.35	[Extension of cervix cancer screening by visual methods to the community health centres in the district of Bamako]. ( Bayo, S; Dembele, Y; Diallo, D; Diané, M; Diarra, MH; Dolo, AI; Kaloga, I; Kamaté, B; Keita, B; Mariko, H; Ouattara, AT; Sacko, R; Sanogo, A; Tall, K; Teguete, B; Togola, B; Toure, M; Traoré, AC; Traoré, CB; Traoré, M; Traore, Y, 2008)
"In the northern region of Brazil, cervical cancer is the most important cause of cancer-related deaths among women."	1.34	The impact of a community intervention to improve cervical cancer screening uptake in the Amazon region of Brazil. ( Derchain, SF; Sarian, LO; Thuler, LC; von Zuben, MV; Westin, MC; Zeferino, LC, 2007)
"Treatment of cervical cancer in developing countries is highly dependent on the resources and skills available."	1.34	Cervical cancer in developing countries: how can we reduce the burden? Awareness raising, screening, treatment and palliation. ( Ansink, AC, 2007)
"Cervical cancer is an important health problem in developing countries."	1.34	Cervical cancer in developing countries: how can we reduce the burden? Awareness raising, screening, treatment and palliation. ( Ansink, AC, 2007)
"Women undergoing cervical cancer screening in Honduras received either VIA and PAP smears (VIA/PAP group) or PAP smears alone (PAP-only group)."	1.34	Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned? ( Figueroa, J; Langrish, SM; Perkins, RB; Simon, CJ; Stern, LJ, 2007)
"Microinvasive squamous cell carcinomas were rare (2."	1.33	[Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)]. ( Eav, S; Kahler, K; Kruy, LS; Lieng, CR; Monchy, D, 2005)
"Uterine cervix cancer is an important public health problem in developing countries."	1.33	[Diagnosis and treatment of invasive cervical cancer in Cambodia (apropos of 35 cases)]. ( Eav, S; Kahler, K; Kruy, LS; Lieng, CR; Monchy, D, 2005)
"Acetic acid smear test was performed on 1997 previously unscreened women aged 35-45 years in Xiangyuan County, Shanxi Province."	1.32	[Value of acetic acid smear test for cervical cancer screening]. ( Belinson, JL; Li, L; Li, N; Pan, QJ; Pretorius, RG; Qiao, YL; Rong, SD; Wu, LY; Zhang, WH; Zhao, FH, 2003)
"At present, the incidence of cervical cancer is still high in less developed areas of China; one of the reasons is that cytology in screening for cervical cancer is not feasible in these areas."	1.32	[Value of acetic acid smear test for cervical cancer screening]. ( Belinson, JL; Li, L; Li, N; Pan, QJ; Pretorius, RG; Qiao, YL; Rong, SD; Wu, LY; Zhang, WH; Zhao, FH, 2003)
"India is a high-risk country for cervical cancer which accounts a quarter (126,000 new cases, 71,000 deaths around 2,000) of the world burden."	1.32	Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. ( Basu, P; Budukh, A; Dinshaw, K; Nene, BM; Parkin, DM; Rajkumar, R; Sankaranarayanan, R; Sharma, R; Shastri, S; Thara, S; Wesley, R, 2003)
"A voluntary screening of uterus cervix cancer took place in Kossodo health district from February 1st 2001 to April 30th 2002."	1.32	[Cervix cancer screening in a health district (Burkina Faso) by voluntary biopsies after the application of acetic acid and lugol]. ( Akotionga, M; Lankoande, J; Millogo, FT, 2004)
"Normal and malignant human cervical cancer cells were imaged in vivo with confocal, phase contrast, and brightfield microscopies."	1.31	Contrast agents for confocal microscopy: how simple chemicals affect confocal images of normal and cancer cells in suspension. ( Collier, T; Drezek, R; Follen, M; Lotan, R; Richards-Kortum, R; Zuluaga, AF, 2002)
"About 80% of cervical cancers occur in less-developed countries."	1.31	Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. ( Blumenthal, PD; Gaffikin, L; King, J; Lawrence, WF; Limpahayom, KK; Lumbiganon, P; Mandelblatt, JS; Ringers, P; Warakamin, S; Yi, B, 2002)
"The predominance of cervical cancer in India can mostly be attributed to the lack of early screening."	1.31	Oncogenic human papillomavirus (HPV) infection and uterine cervical cancer: a screening strategy in the perspective of rural India. ( Bhattacharya, P; Chakraborty, S; Duttagupta, C; Ghosh, S; Roy, M; Roy, S; Sengupta, D; Sengupta, S, 2002)
"As part of a study of archival cervical cancer specimens (1920s to 1980s) to determine whether changes have occurred in the prevalence of human papillomavirus (HPV) DNAs, investigations were performed on tissues which had been fixed in either 10% buffered formalin (NBF) or formalin-acetic acid-alcohol (FAA)."	1.28	Deleterious effects of formalin/acetic acid/alcohol (FAA) fixation on the detection of HPV DNA by in situ hybridization and the polymerase chain reaction. ( Rose, BR; Thompson, CH, 1991)

Research

Studies (376)

Authors

Clinical Trials (16)

Trial Overview

Trial Outcomes

Agreement of Acetic Acid Chromoendoscopic Reading Between the Two Endoscopists

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (0.80)	18.7374
1990's	23 (6.12)	18.2507
2000's	94 (25.00)	29.6817
2010's	193 (51.33)	24.3611
2020's	63 (16.76)	2.80

Authors	Studies
Destaw, A	1
Midaksa, M	1
Addissie, A	3
Kantelhardt, EJ	2
Gizaw, M	2
Shahnaz, S	1
Hira, HM	1
Begum, KN	1
Akhter, R	2
Sharmin, S	1
Chinn, JO	1
Runge, AS	1
Dinicu, AI	1
Chang, J	1
Maher, JA	1
Crawford, EW	1
Naaseh, A	1
Cooper, EC	1
Zezoff, DC	1
White, KM	1
Lucas, AN	1
Bera, KR	1
Bernstein, M	1
Hari, A	1
Ziogas, A	1
Tewari, SE	1
Pearre, DC	1
Tewari, KS	2
Qayum, MO	1
Billah, MM	1
Flora, MS	1
Awolude, OA	1
Oyerinde, SO	1
Ayeni, AO	1
Adewole, IF	2
Jeffries, A	1
Beck-Sagué, CM	1
Marroquin-Garcia, AB	1
Dean, M	1
McCoy, V	1
Cordova-Toma, DA	1
Fenkl, E	1
Madhivanan, P	2
Baleydier, I	1
Vassilakos, P	11
Viñals, R	1
Wisniak, A	5
Kenfack, B	5
Tsuala Fouogue, J	2
Enownchong Enow Orock, G	1
Lemoupa Makajio, S	1
Foguem Tincho, E	1
Undurraga, M	1
Cattin, M	1
Makohliso, S	1
Schönenberger, K	1
Gervaix, A	1
Thiran, JP	1
Petignat, P	11
Allanson, ER	1
Phoolcharoen, N	2
Salcedo, MP	2
Fellman, B	1
Schmeler, KM	2
Varon, ML	1
Baker, E	1
Parra, S	1
Carns, J	1
Cherry, K	1
Smith, C	1
Sonka, T	1
Doughtie, K	1
Lorenzoni, C	2
Richards-Kortum, R	2
Schmeler, K	1
Hayumbu, V	1
Hangoma, J	1
Hamooya, BM	1
Malumani, M	1
Masenga, SK	1
Lohiya, A	1
Daniel, RA	1
Kumar, D	1
Varghese, C	1
Rath, RS	1
S A, R	1
Nongkynrih, B	1
Saiji, E	1
Tille, JC	1
Catarino, R	7
Tincho, E	2
Dufeil, E	1
Fouogue, J	1
Sormani, J	1
Sauvaget, C	7
Bazikamwe, S	1
Lucas, E	6
Ndayikengurukiye, A	1
Harerimana, S	1
Barango, P	1
Ginindza, TG	2
Forestier, M	1
Almonte, M	5
Hu, SY	6
Zhao, XL	2
Zhao, FH	10
Wei, LH	1
Zhou, Q	2
Niyazi, M	1
Liu, JH	1
Wang, CY	1
Li, LY	1
Cheng, XD	1
Duan, XZ	2
Qiao, YL	13
Sankaranarayanan, R	34
Agustiansyah, P	1
Nurmaini, S	1
Nuranna, L	1
Irfannuddin, I	1
Sanif, R	1
Legiran, L	1
Rachmatullah, MN	1
Florina, GO	1
Sapitri, AI	1
Darmawahyuni, A	1
Selmouni, F	3
Dangbemey, DP	1
Kpebo, DDO	1
Dieng, NM	1
Chami Khazraji, Y	1
Bennani, M	1
Bekkali, R	1
Basu, P	15
Kahesa, C	4
Thomsen, LT	1
Linde, DS	1
Mchome, B	1
Katanga, J	1
Swai, P	1
Manongi, R	1
Kjaerem, M	2
Iftner, T	3
Waldstrøm, M	1
Mwaiselage, J	4
Rasch, V	3
Kjaer, SK	3
John, JH	1
Halder, A	1
Purwar, S	1
Pushpalatha, K	1
Gupta, P	1
Dubey, P	1
Herrick, T	1
Thomson, KA	2
Shin, M	1
Gannon, S	1
Tsu, V	1
de Sanjosé, S	2
Baena, A	3
Mesher, D	3
Salgado, Y	3
Martínez, S	3
Villalba, GR	3
Amarilla, ML	3
Salgado, B	3
Flores, B	3
Bellido-Fuentes, Y	3
Álvarez-Larraondo, M	3
Valls, J	3
Lora, O	3
Virreira-Prout, G	3
Figueroa, J	5
Turcios, E	3
Soilán, AM	3
Ortega, M	3
Celis, M	3
González, M	4
Venegas, G	4
Terán, C	3
Ferrera, A	3
Mendoza, L	3
Kasamatsu, E	3
Murillo, R	5
Wiesner, C	3
Broutet, N	4
Luciani, S	5
Herrero, R	3
Sirait, LMF	2
Hamajima, N	2
Suzuki, Y	2
Wahyuningsih, ES	2
Oktavia, D	2
Inthaphatha, S	2
Nishino, K	2
Yamamoto, E	2
Mulmi, R	1
Shrestha, G	1
Pathak, A	1
Sharma, M	1
Dawadi, T	1
Siwakoti, B	1
Pradhananga, KK	1
Natarajan, J	1
Mathur, S	1
Vishnubhatla, S	1
Kumar, S	1
Vashist, S	1
Ramanujam, N	2
Singhal, S	2
Meena, J	1
Tanwar, P	1
Bhatla, N	5
Joseph, J	1
Demke, O	1
Ameyan, L	1
Bitilinyu-Bango, J	1
Bourgoin, B	1
Diop, M	1
Guèye, B	1
Kama, J	1
Lubega, M	1
Madzima, B	1
Maparo, T	1
Mhizha, T	1
Musoke, A	1
Nabadda, S	1
Phiri, T	1
Tchereni, T	1
Wiwa, O	1
Hariharan, K	1
Peter, T	1
Khan, S	1
Benkortbi, K	1
Tincho Foguem, E	1
Mulindi, M	1
Horo, A	2
Jeronimo, J	12
Balli, C	1
Abatsong, E	1
Mergui, JL	1
Gondry, J	1
Hocquemiller, R	1
Carcopino, X	1
Zhou, Y	1
Wang, C	2
Li, W	2
Lu, W	1
Liu, X	1
Xi, L	1
Li, P	1
Lu, J	1
Wei, J	1
Sineque, A	1
Catalao, C	1
Ceffa, S	1
Fonseca, AM	1
Parruque, F	1
Guidotti, G	1
Massango, C	1
Carrilho, C	1
Bicho, C	1
Rangeiro, R	1
Orlando, S	1
Marazzi, MC	1
Ciccacci, F	1
Mwenda, V	1
Bor, JP	1
Nyangasi, M	1
Njeru, J	1
Olwande, S	1
Njiri, P	1
Arbyn, M	5
Weyers, S	1
Tummers, P	1
Temmerman, M	3
Shin, MB	1
Oluoch, LM	1
Barnabas, RV	1
Baynes, C	1
Fridah, H	1
Heitner, J	1
Kerubo, MB	1
Ngure, K	1
Pinder, LF	3
Thomas, KK	1
Mugo, NR	1
Gimbel, S	1
Ogunsola, OO	2
Olawepo, JO	1
Ajayi, O	1
Osayi, E	2
Akinro, YT	1
Ifechelobi, C	2
Chigbu, C	1
Okonkwo, P	2
Ezeanolue, EE	1
Hon, HJ	1
Chong, PP	1
Choo, HL	1
Khine, PP	1
Kagoné, TS	1
Paré, PG	1
Dembélé, A	1
Kania, D	1
Zida, S	1
Bonané/Thiéba, B	1
Ouédraogo, A	1
Testa, J	1
Simporé, J	1
Méda, N	3
Ajayi, OA	1
Ojo, TO	1
Wudiri, K	1
Amoo, B	1
Ayoka-Ikechukwu, R	1
Olumeyan, OO	1
Akinro, Y	1
Nakisige, C	2
de Fouw, M	1
Kabukye, J	1
Sultanov, M	1
Nazrui, N	1
Rahman, A	1
de Zeeuw, J	1
Koot, J	1
Rao, AP	1
Prasad, K	3
Shyamala, G	1
Siddharta, P	1
Stekelenburg, J	1
Beltman, JJ	1
Wagner, GJ	1
Matovu, JKB	1
Juncker, M	1
Namisango, E	1
Beyeza-Kashesya, J	1
Wanyenze, RK	1
Brevik, TB	1
da Matta Calegari, LR	1
Mosquera Metcalfe, I	1
Laake, P	1
Maza, M	4
Todd, A	1
Carvalho, AL	1
Tassembedo, S	1
Winter, CH	1
Traore, IT	1
Ouattara, A	1
Sawadogo, M	1
Winata, IGS	2
Paramitha, PP	2
Yusrika, MU	2
Anderson, JR	1
Yogeshkumar, S	1
Lu, E	4
Yenokyan, G	1
Thaler, K	1
Mensa, M	1
Chikaraddi, S	1
Lokare, L	1
Gudadinni, MR	1
Antartani, R	1
Donimath, K	1
Patil, B	1
Bidri, S	1
Goudar, SS	1
Derman, R	1
Dalal, A	3
Verma, ML	1
Sharma, P	1
Singh, U	1
Sachan, R	1
Sankhwar, PL	1
Tachiwenyika, E	1
Dhodho, M	1
Muchedzi, A	1
Sibanda, TP	1
Mupanguri, C	1
Mukungunugwa, S	1
Mhangara, M	1
Ganje, N	1
Tapera, T	1
Samushonga, T	1
Muzondo, M	1
Dube, S	1
Tafuma, T	1
Chingombe, B	1
Maravanyika, A	1
Nyamundaya, T	1
Belglaiaa, E	1
Mougin, C	1
Lidofsky, A	1
Miller, A	1
Jorgensen, J	1
Tajik, A	1
Tendeu, K	1
Pius, D	1
Mallange, E	1
Dougherty, A	1
Parham, GP	4
Muwonge, R	21
Nyambe, N	1
Mwanahamuntu, MH	3
Prendiville, W	3
Saraiya, U	1
Srivastava, S	1
Bhalerao, S	1
Shamsunder, S	1
Chavan, N	1
Purandare, CN	1
Bae, JK	1
Roh, HJ	1
You, JS	1
Kim, K	1
Ahn, Y	1
Askaruly, S	1
Park, K	1
Yang, H	1
Jang, GJ	1
Moon, KH	1
Jung, W	1
Dykens, JA	1
Smith, JS	6
Demment, M	1
Marshall, E	1
Schuh, T	1
Peters, K	1
Irwin, T	1
McIntosh, S	1
Sy, A	1
Dye, T	1
Napitupulu, D	1
Puspitaningtyas, H	1
Mualim, K	1
Kusumanto, A	1
Lazuardi, L	1
Hutajulu, SH	1
Sandoval, M	1
Bain, C	1
Holme, F	1
Bansil, P	5
Fentie, AM	1
Tadesse, TB	1
Gebretekle, GB	1
Tesfaw, G	1
Ahmed, Y	1
Gedefaw, L	1
Dube, L	1
Godu, S	1
Eshetu, K	1
Nigussie, M	1
Hailekiros, H	1
Joloba, M	1
Goba, G	1
Abdissa, A	1
Corrado, G	1
Mazzara, C	1
Certelli, C	1
Nsubuga, JB	1
Zanetto, F	1
Schurfeld, K	1
Dell'Antonio, G	1
Orti, CD	1
Savarese, A	1
Andriani, MT	1
Hailemariam, G	1
Gebreyesus, H	1
Wubayehu, T	1
Gebregyorgis, T	1
Gebrecherkos, K	1
Teweldemedhin, M	1
Kifle, M	1
Shrestha, B	1
Malla Vaidya, K	1
Joshi, R	1
Rahatgaonkar, V	1
Uchale, P	1
Oka, G	1
Ploysawang, P	1
Rojanamatin, J	1
Prapakorn, S	1
Jamsri, P	1
Pangmuang, P	1
Seeda, K	1
Sangrajrang, S	1
Mattick, LJ	1
Ochs-Balcom, HM	1
Gard, AC	1
Shalan, F	1
Soliman, AS	1
Chinula, L	1
Topazian, HM	1
Mapanje, C	1
Varela, A	1
Chapola, J	1
Limarzi, L	1
Stanley, C	1
Hosseinipour, M	1
Gopal, S	1

Trial	Phase	Enrollment	Study Type	Start Date	Status
Study Protocol for a Two-site Clinical Trial to Validate a Smartphone-based Artificial Intelligence Classifier Identifying Cervical Precancer and Cancer in HPV-positive Women in Cameroon[NCT04859530]		5,886 participants (Anticipated)	Interventional	2018-08-01	Recruiting
Promoting Comprehensive Cervical Cancer Prevention and Better Women Health in Cameroon[NCT03757299]		4,473 participants (Actual)	Interventional	2018-10-01	Active, not recruiting
Evaluating Thermal Ablation in the Treatment of Cervical Neoplasia[NCT05211271]		86 participants (Actual)	Interventional	2018-10-01	Completed
Development, Field Testing and Evaluation of the Efficacy of a Hand-held, Portable and Affordable Thermo-coagulator to Prevent Cervical Cancer in Low- and Middle-income Countries[NCT02956239]		450 participants (Anticipated)	Interventional	2017-08-01	Active, not recruiting
Development of a Two-stage Cervical Cancer Screening Algorithm for Botswana[NCT03324009]		239 participants (Actual)	Interventional	2018-04-20	Completed
Safety and Validity Evaluation for Cervical Cancer Screening and Treatment Techniques Among HIV-infected Women[NCT02237326]		654 participants (Actual)	Interventional	2011-10-31	Completed
Efficacy of a Combined Program for Early Detection of Breast and Gynecological Cancers in Low Resource Countries[NCT01178736]		36,000 participants (Anticipated)	Observational	2011-03-31	Not yet recruiting
Mobile High-Resolution Microendoscopy (mHRME) for the Detection of Cervical Dysplasia in El Salvador[NCT04472455]		1,827 participants (Actual)	Observational	2015-09-30	Completed
Z 1313 - Comparison of Point-of-care Molecular Tests and Visual Inspection With Acetic Acid for Cervical Cancer Screening in HIV-infected Women in Lusaka, Zambia[NCT02688816]		200 participants (Actual)	Observational	2014-08-31	Completed
Feasibility and Acceptability of HPV Self-Collection Cervical Cancer Screening and Treatment in Clinics and the Community in Botswana[NCT03345875]		1,022 participants (Actual)	Interventional	2017-10-16	Completed
"Study of the Diagnostic Efficacy of Real Time Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix (PUSHOCTII)"[NCT01766284]		100 participants (Anticipated)	Interventional	2012-11-30	Completed
Performance, Safety, and Efficacy of a New Cryotherapy Device for Cervical Dysplasia[NCT04154644]		15 participants (Actual)	Interventional	2019-04-09	Completed
Acetic Acid Chromoendoscopy for Judging Extent of Gastric Intestinal Metaplasia[NCT01499576]		126 participants (Actual)	Interventional	2011-11-30	Completed
Efficiency of AV2 Antiviral Drug in the Treatment of Human Papillomavirus-associated Precancerous Lesions of the Uterine Cervix: a Randomized Clinical Trial in Kinshasa, Democratic Republic of the Congo[NCT02346227]	Phase 3	327 participants (Actual)	Interventional	2015-01-31	Completed
Safety and Efficacy of Two Screen-and-Treat Approaches for the Prevention of Cervical Cancer[NCT00233727]	Phase 3	7,123 participants (Actual)	Interventional	2000-01-31	Terminated (stopped due to PI left University)
Pilot Study of a Mobile Health Approach to Reduce Barriers to Cervical Cancer Screening in Tanzania[NCT02680613]		851 participants (Actual)	Interventional	2016-02-29	Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

"The findings of chromoendoscopy will be interpretated by two endoscoipists (read as positive or negative finding) independently.~We calculate the Kappa index of agreement for the acetic acid chromoendoscopy." (NCT01499576)
Timeframe: One month after the completion of the study

Number of Participants With Adverse Events

Intervention	Kappa index of agreement (Number)
Acetic Acid Spraying	0.808

Number of Participants with Adverse Events. Assess kind of side effect and severity. Measured by interview with a physician, just after the procedure and 1weak later. (NCT01499576)
Timeframe: up to 1week after the acetic acid chromoendoscopy

Percent Agreement Between Acetic Acid Chromoendoscopy and Endoscopic Biopsy

Intervention	participants (Number)
	Epigastric discomfort	Neck discomfort
Acetic Acid Spraying	9	2

Endoscopist judges the presence and the extent of gastric intestinal metaplasia during acetic acid chromoendoscopy. Endoscopist perform five endoscopic biopsies according to the protocol. The degree of agreement between the chromoendoscopy and the endoscopic biopsy is assessed as %. (NCT01499576)
Timeframe: 3 months after the completion of the study (a pathologist reviewed all the biopsy slide)

Intervention	percentage of lesions (Number)
	Overall Sensitivity	Overall Specificity	Overall Accuracy	Body Sensitivity	Body Specificity	Body Accuracy	Antrum Sensitivity	Antrum Specificity	Antrum Accuracy
Acetic Acid Spraying	78.5	94.4	89.2	67.1	94.7	89.4	80.9	93.6	88.4

Article	Year
ABCD criteria to improve visual inspection with acetic acid (VIA) triage in HPV-positive women: a prospective study of diagnostic accuracy. BMJ open, 2022, 04-04, Volume: 12, Issue:4 Topics: Acetic Acid; Adult; Early Detection of Cancer; Female; Humans; Middle Aged; Papillomavirus Infection	2022
Can portable Colposcopes Replace Standard-of-care Colposcopes? A Crossover Trial of Two Portable Colposcopes with a Standard-of-Care Video Colposcope. Asian Pacific journal of cancer prevention : APJCP, 2022, Dec-01, Volume: 23, Issue:12 Topics: Acetic Acid; Colposcopes; Colposcopy; Cross-Over Studies; Early Detection of Cancer; Female; Humans;	2022
Transformation Zone Assessment Using Visual Inspection With Acetic Acid Before and After Thermal Ablation: Implications for Follow-Up. JCO global oncology, 2023, Volume: 9 Topics: Acetic Acid; Early Detection of Cancer; Female; Follow-Up Studies; Humans; Prospective Studies; Uter	2023
Fluorescence colposcope with TMTP1-PEG4-ICG is comparable to the conventional colposcope in identifying cervical precancerous lesions: A randomized controlled trial. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2023, Volume: 162, Issue:3 Topics: Acetic Acid; Cervix Uteri; Colposcopes; Early Detection of Cancer; Female; Humans; Precancerous Cond	2023
Implementation and scale-up of a single-visit, screen-and-treat approach with thermal ablation for sustainable cervical cancer prevention services: a protocol for a stepped-wedge cluster randomized trial in Kenya. Implementation science : IS, 2023, 06-26, Volume: 18, Issue:1 Topics: Acetic Acid; Early Detection of Cancer; Female; Humans; Kenya; Mass Screening; Precancerous Conditio	2023
Knowledge Mediates the Effects of Game Changers for Cervical Cancer Prevention (GC-CCP) Intervention on Increased VIA Screening Advocacy in Uganda. Cancer prevention research (Philadelphia, Pa.), 2023, Dec-01, Volume: 16, Issue:12 Topics: Acetic Acid; Cervix Uteri; Early Detection of Cancer; Female; Humans; Mass Screening; Uganda; Uterin	2023
Comparison of acceptability & efficacy of thermal ablation (thermocoagulation) & cryotherapy in VIA positive cervical lesions: A pilot study. The Indian journal of medical research, 2023, Oct-01, Volume: 158, Issue:4 Topics: Acetic Acid; Cryotherapy; Electrocoagulation; Female; Humans; Pilot Projects; Uterine Cervical Dyspl	2023
Thermal ablation versus cryotherapy or loop excision to treat women positive for cervical precancer on visual inspection with acetic acid test: pilot phase of a randomised controlled trial. The Lancet. Oncology, 2020, Volume: 21, Issue:1 Topics: Acetic Acid; Adult; Cryotherapy; Early Detection of Cancer; Electrosurgery; Female; Follow-Up Studie	2020
Uptake of Cervical Cancer Screening in Ethiopia by Self-Sampling HPV DNA Compared to Visual Inspection with Acetic Acid: A Cluster Randomized Trial. Cancer prevention research (Philadelphia, Pa.), 2019, Volume: 12, Issue:9 Topics: Acetic Acid; Adult; Cervix Uteri; Cluster Analysis; Diagnostic Self Evaluation; Diagnostic Technique	2019
Evaluation of a 5-year cervical cancer prevention project in Indonesia: opportunities, issues, and challenges. The journal of obstetrics and gynaecology research, 2013, Volume: 39, Issue:6 Topics: Acetic Acid; Adult; Community Health Centers; Cryotherapy; False Positive Reactions; Female; Humans;	2013
Evaluation of stationary colposcope and the Gynocular, by the Swede score systematic colposcopic system in VIA positive women: a crossover randomized trial. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:2 Topics: Acetic Acid; Adult; Colposcopy; Cross-Over Studies; Female; Humans; Uterine Cervical Dysplasia; Uter	2014
A multicountry evaluation of careHPV testing, visual inspection with acetic acid, and papanicolaou testing for the detection of cervical cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2014, Volume: 24, Issue:3 Topics: Acetic Acid; Adult; Alphapapillomavirus; Developing Countries; DNA, Viral; Feasibility Studies; Fema	2014
Effect of VIA screening by primary health workers: randomized controlled study in Mumbai, India. Journal of the National Cancer Institute, 2014, Volume: 106, Issue:3 Topics: Acetic Acid; Adult; Early Detection of Cancer; Female; Follow-Up Studies; Health Education; Humans;	2014
Cervical cancer screening in sub-Saharan Africa: a randomized trial of VIA versus cytology for triage of HPV-positive women. International journal of cancer, 2015, Jul-01, Volume: 137, Issue:1 Topics: Acetic Acid; Adult; Africa South of the Sahara; Aged; Alphapapillomavirus; Female; Humans; Middle Ag	2015
A randomized trial comparing the diagnostic accuracy of visual inspection with acetic acid to Visual Inspection with Lugol's Iodine for cervical cancer screening in HIV-infected women. PloS one, 2015, Volume: 10, Issue:4 Topics: Acetic Acid; Adult; Coloring Agents; Colposcopy; Early Detection of Cancer; Female; HIV; HIV Infecti	2015
Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial. Tropical medicine & international health : TM & IH, 2015, Volume: 20, Issue:10 Topics: Acetic Acid; Adult; Early Detection of Cancer; Feasibility Studies; Female; Humans; Indicators and R	2015
The performance of Dynamic Spectral Imaging colposcopy depends on indication for referrals. Gynecologic oncology, 2015, Volume: 139, Issue:3 Topics: Acetic Acid; Adolescent; Adult; Cervix Uteri; Colposcopy; Early Detection of Cancer; Female; Humans;	2015
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
HPV screening for cervical cancer in rural India. The New England journal of medicine, 2009, Apr-02, Volume: 360, Issue:14 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cytological Techniques; Female; Humans; Incidence; India; Ma	2009
Effect of single-visit VIA and cryotherapy cervical cancer prevention program in Roi Et, Thailand: a preliminary report. The journal of obstetrics and gynaecology research, 2010, Volume: 36, Issue:1 Topics: Acetic Acid; Adult; Cryotherapy; Early Detection of Cancer; Female; Humans; Incidence; Indicators an	2010
Comparison of Papanicolaou test with visual detection tests in screening for cervical cancer and developing the optimal strategy for low resource settings. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2010, Volume: 20, Issue:5 Topics: Acetic Acid; Adolescent; Adult; Cross-Sectional Studies; Diagnostic Techniques, Obstetrical and Gyne	2010
[Comparison of the diagnostic utility from visual inspection with acetic acid and cervical cytology]. Ginecologia y obstetricia de Mexico, 2010, Volume: 78, Issue:5 Topics: Acetic Acid; Adolescent; Adult; Biopsy; Colposcopy; Double-Blind Method; Female; Humans; Middle Aged	2010
Acetic-acid guided visual inspection vs. cytology-based screening for cervical cancer in the Philippines. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2003, Volume: 83, Issue:2 Topics: Acetic Acid; Adult; Attitude; Biopsy; Colposcopy; Female; Humans; Indicators and Reagents; Mass Scre	2003
Determinants of participation of women in a cervical cancer visual screening trial in rural south India. Cancer detection and prevention, 2003, Volume: 27, Issue:6 Topics: Acetic Acid; Adult; Female; Humans; Incidence; India; Mass Screening; Middle Aged; Patient Acceptanc	2003
Initial results from a randomized trial of cervical visual screening in rural south India. International journal of cancer, 2004, Apr-10, Volume: 109, Issue:3 Topics: Acetic Acid; Adult; Developing Countries; Female; Humans; Incidence; India; Mass Screening; Middle A	2004
A clinical study of optical biopsy of the uterine cervix using a multispectral imaging system. Gynecologic oncology, 2005, Volume: 96, Issue:1 Topics: Acetic Acid; Adolescent; Adult; Biopsy; Cervix Uteri; Colposcopy; False Positive Reactions; Female;	2005
A cluster randomized controlled trial of visual, cytology and human papillomavirus screening for cancer of the cervix in rural India. International journal of cancer, 2005, Sep-10, Volume: 116, Issue:4 Topics: Acetic Acid; Adult; Cost Control; Cytological Techniques; DNA, Viral; Female; Humans; India; Mass Sc	2005
Visual inspection with acetic acid and cytology as screening methods for cervical lesions in Cameroon. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2005, Volume: 89, Issue:2 Topics: Acetic Acid; Adult; Biopsy, Needle; Cameroon; Cervix Uteri; Colposcopy; Cross-Sectional Studies; Fem	2005
Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA, 2005, Nov-02, Volume: 294, Issue:17 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cryotherapy; DNA, Viral; Female; Health Resources; Health Se	2005
Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA, 2005, Nov-02, Volume: 294, Issue:17 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cryotherapy; DNA, Viral; Female; Health Resources; Health Se	2005
Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA, 2005, Nov-02, Volume: 294, Issue:17 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cryotherapy; DNA, Viral; Female; Health Resources; Health Se	2005
Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA, 2005, Nov-02, Volume: 294, Issue:17 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cryotherapy; DNA, Viral; Female; Health Resources; Health Se	2005
Visual inspection as a cervical cancer screening method in a primary health care setting in Africa. International journal of cancer, 2006, Sep-15, Volume: 119, Issue:6 Topics: Acetic Acid; Adult; Biopsy; Colposcopy; Cross-Sectional Studies; Democratic Republic of the Congo; F	2006
Assessment of 2 cervical screening methods in Mongolia: cervical cytology and visual inspection with acetic acid. Journal of lower genital tract disease, 2006, Volume: 10, Issue:2 Topics: Acetic Acid; Adult; Aged; Biopsy; Cervix Uteri; Colposcopy; Female; Humans; Indicators and Reagents;	2006
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet (London, England), 2007, Aug-04, Volume: 370, Issue:9585 Topics: Acetic Acid; Adult; Female; Humans; Incidence; India; Indicators and Reagents; Mass Screening; Middl	2007
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet (London, England), 2007, Aug-04, Volume: 370, Issue:9585 Topics: Acetic Acid; Adult; Female; Humans; Incidence; India; Indicators and Reagents; Mass Screening; Middl	2007
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet (London, England), 2007, Aug-04, Volume: 370, Issue:9585 Topics: Acetic Acid; Adult; Female; Humans; Incidence; India; Indicators and Reagents; Mass Screening; Middl	2007
Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet (London, England), 2007, Aug-04, Volume: 370, Issue:9585 Topics: Acetic Acid; Adult; Female; Humans; Incidence; India; Indicators and Reagents; Mass Screening; Middl	2007
Is magnification necessary to confirm visual inspection of cervical abnormalities? A randomized trial in Peru. Revista panamericana de salud publica = Pan American journal of public health, 2008, Volume: 23, Issue:1 Topics: Acetic Acid; Adult; Biopsy; Cervix Uteri; Colposcopy; Confidence Intervals; Female; Follow-Up Studie	2008
Speculoscopy vs. the acetic acid test for cervical neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 2000, Volume: 69, Issue:3 Topics: Acetic Acid; Adult; Aged; Colposcopy; Female; Humans; Indicators and Reagents; Middle Aged; Sensitiv	2000
A novel optical imaging method for the early detection, quantitative grading, and mapping of cancerous and precancerous lesions of cervix. IEEE transactions on bio-medical engineering, 2001, Volume: 48, Issue:1 Topics: Acetic Acid; Adult; Carcinoma in Situ; Colposcopes; Colposcopy; Diagnosis, Differential; Diagnostic	2001
Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer, 2002, Mar-15, Volume: 94, Issue:6 Topics: Acetic Acid; Adult; Aged; Carcinoma, Squamous Cell; Colposcopy; DNA, Viral; Female; Humans; Mass Scr	2002
Acetic acid test: a promising screening test for early detection of cervical cancer. Analytical and quantitative cytology and histology, 2002, Volume: 24, Issue:3 Topics: Acetic Acid; Female; Humans; Indicators and Reagents; Mass Screening; Predictive Value of Tests; Sen	2002

acetic acid and Cancer of Cervix